Drug application
BETAMETHASONE SODIUM PHOSPHATE (BETAMETHASONE SODIUM PHOSPHATE)
Drugs@FDA ANDA 085738 · WATSON LABS
Key facts
| Drug name | BETAMETHASONE SODIUM PHOSPHATE |
|---|---|
| Active ingredients | BETAMETHASONE SODIUM PHOSPHATE |
| Application type | ANDA |
| Application number | 085738 |
| Company | WATSON LABS |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | EQ 3MG BASE/ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Jan 30, 1979 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.